The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 337:418-419 August 7, 1997 Number 6
NextNext

Restenosis Revisited — New Targets, New Therapies

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Respite gratifying immediate results, progressive narrowing of the coronary arteries over several months all too commonly limits the benefit of balloon angioplasty and various types of atherectomy. Even coronary-artery stents, which achieve a splendid luminal expansion in the short term, often elicit substantial recurrent stenosis with time. Finding effective therapies to combat restenosis after coronary intervention has been difficult. Now Tardif et al., in an admirably designed study reported in this issue of the Journal,1 show that treatment with a multifunctional agent, probucol, substantially reduces luminal narrowing after balloon coronary angioplasty. Their striking results raise challenging questions about the mechanisms . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.